Ovintiv Inc. (OVV) SEC Filings & Earnings Calls
EquiReason read 25 Ovintiv Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-01 — Ovintiv renewed NCIB to buy back up to 26,973,037 shares (10% of float) over 12 months, consistent with 50-100% FCF return policy..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 19.9B
- P/E TTM
- —
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
1 Oct 20268-K · 7.01Ovintiv renewed NCIB to buy back up to 26,973,037 shares (10% of float) over 12 months, consistent with 50-100% FCF return policy.open
Figures in the filing · each found in the filing text
| Shares Authorized for Repurchase · 2026-10-05 to 20 | 26,973,037 | |
| Shares Repurchased Under Prior NCIB · 2025-10-03 to 20 | 13,925,579 | |
| Weighted Average Purchase Price (Prior NCIB) · 2025-10-03 to 20 | $58.49 | |
| Q3 2026 Shares Repurchased · Q3-2026 | 6,332,551 | |
| Q3 2026 Weighted Average Purchase Price · Q3-2026 | $60.90 |
Risks flagged
Buyback execution depends on commodity prices and cash flow generation.
“ability to generate sufficient cash flow to meet obligations and fund the NCIB” · word for word
27 Aug 20268-K · 7.01Ovintiv added 41,000 net acres across Permian and Montney for $460M; 240 net well locations added; $11,000/acre valuation.open
Figures in the filing · each found in the filing text
| net acres added · 2026-YTD | 41,000 | |
| total acquisition cost · 2026-YTD | $460M | |
| net well locations added · 2026-YTD | 240 | |
| cost per net acre · 2026-YTD | $11000.00 |
Risks flagged
Execution risk on closing remaining transactions before year-end
“Ovintiv expects the remaining transactions to close before the end of the year” · word for word
23 Jul 202610-QOvintiv reported Q2 2026 operating income of $994M, up 94% YoY, driven by higher revenues and the NuVista acquisition, but recorded significant H1 impairments.earningsopen
Figures in the filing · each found in the filing text
| Product and service revenues · Q2-2026 | $2.30B | +30% y/y |
| Net earnings (loss) · Q2-2026 | $456M | +49% y/y |
| Cash from operating activities · Q2-2026 | $1.63B | +61% y/y |
| Capital expenditures · Q2-2026 | $574M | +10% y/y |
| Impairments · H1-2026 | $1.49B | +103% y/y |
Risks flagged
Commodity price exposure
“For the six months ended June 30, 2026, the Company recognized before-tax non-cash ceiling test impairments of $1,485 million, comprising $1,111 million in the USA Operations and $374 million in the Canadian Operations. The non-cash ceiling test impairments primarily resulted from declines in the 12-month average trailing prices” · word for word
Integration risk from acquisitions
“The assets acquired are strategically located in close proximity to Ovintiv’s current operations and add approximately 930 net well locations and approximately 140,000 net acres in the core of the condensate-rich Montney in Alberta.” · word for word
23 Jul 20268-K · 2.02, 8.01Total Revenues $3.01B (+30% y/y); Net Earnings $456M (+48% y/y); Cash From Operating Activities $1.63B (+61% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q2-2026 | $3.01B | +30% y/y |
| Net Earnings · Q2-2026 | $456M | +49% y/y |
| Cash From Operating Activities · Q2-2026 | $1.63B | +61% y/y |
| Capital expenditures · Q2-2026 | $574M | +10% y/y |
| Impairments · Q2-2026 | $0.00 |
Risks flagged
High debt and interest expense, but manageable with strong cash flow.
“Interest expense $100M, long-term debt $3,695M”
Impairments in H1 2026 ($1,485M) indicate asset write-downs, but none in Q2.
“Impairments $1,485M for six months ended June 30, 2026”
11 May 20268-K · 2.02, 8.01Ovintiv reported Q1 2026 net loss of $630M vs $159M loss in Q1 2025; revenue $2.53B vs $2.38B; impairments of $1.485B vs $730M; adjusted earnings $537M vs $370M; dividend declared $0.30/share.earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q1-2026 | $2.53B | +7% y/y |
| Net Earnings (Loss) · Q1-2026 | $-630M | |
| Non-GAAP Adjusted Earnings · Q1-2026 | $537M | +45% y/y |
| Non-GAAP Cash Flow · Q1-2026 | $1.24B | +23% y/y |
| Capital expenditures · Q1-2026 | $605M | -2% y/y |
| Dividends on shares of common stock · Q1-2026 | $85M | +9% y/y |
Risks flagged
Large impairment charge of $1.485B suggests potential asset devaluation or lower commodity price outlook.
“Impairments: $1,485 million”
Net debt increased to $5.24B from $4.34B a year ago, indicating higher leverage.
“Net debt: $5,241 million”
11 May 202610-QRevenue $2.53B (+6% y/y); Net Income (Loss) $-630M; Operating Cash Flow $1.06B (+21% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $2.53B | +7% y/y |
| Net Income (Loss) · Q1-2026 | $-630M | |
| Operating Cash Flow · Q1-2026 | $1.06B | +21% y/y |
| Capital Expenditures · Q1-2026 | $605M | -2% y/y |
Risks flagged
Ceiling Test Impairment Risk
“For the three months ended March 31, 2026, the Company recognized before-tax non-cash ceiling test impairments of $1,485 million.” · word for word
High Debt Levels Post-Acquisition
“Total Long-Term Debt $ 6,398 $ 5,202” · word for word
Commodity Price Sensitivity
“The non-cash ceiling test impairments primarily resulted from declines in the 12-month average trailing prices.” · word for word
9 Apr 20268-K · 1.02, 2.01, 7.01, 8.01Ovintiv completed sale of Anadarko assets (~360K net acres in Oklahoma) for $2.9B cash; used proceeds to repay C$1.57B credit facility and redeem $700M notes. Also completed NuVista acquisition for ~$2.8B (C$3.8B) in Feb 2026.being acquiredopen
Figures in the filing · each found in the filing text
| acquisition consideration · point_in_time | $2.80B | |
| divestiture consideration · point_in_time | $2.90B | |
| net acres acquired · Montney · point_in_time | 140,000 | |
| net drilling locations · Montney · point_in_time | 930 | |
| net acres divested · Anadarko · point_in_time | 360,000 | |
| debt redeemed · point_in_time | $700M |
Risks flagged
Integration risk from NuVista acquisition and execution of divestiture; debt reduction mitigates financial risk.
“Acquisition of NuVista and divestiture of Anadarko; pro forma adjustments subject to revision.”
25 Mar 2026DEF 14AOvintiv filed its 2026 proxy statement (DEF 14A) detailing executive compensation, governance, and 2025 performance.open
Figures in the filing · each found in the filing text
| Cash from Operating Activities · FY2025 | $3.70B | |
| Production · FY2025 | $615000.00 | |
| Proved Reserves · FY2025 | $2.30B | |
| Shareholder Returns · FY2025 | $600M | |
| Net Debt · FY2025 | $5.17B | |
| Capital Expenditures · FY2025 | $2.15B | |
| Net Income · FY2025 | $1.24B | |
| Scope 1&2 GHG Emissions Intensity Reduction · FY2025 | 9.0% | |
| Total Recordable Injury Frequency · FY2025 | $0.18 |
Guidance
Production guidance raised two times in 2025; capital spend $50M below plan
Ovintiv raised production guidance twice in 2025 while lowering capital investment, indicating strong operational momentum and capital efficiency.
Risks flagged
Commodity Price Volatility
“Despite ongoing macroeconomic and geopolitical uncertainty, Ovintiv’s strategy remains resilient.” · word for word
Integration Risk from M&A
“We seamlessly and safely integrated the Montney oil assets acquired from Paramount Resources Ltd. earlier in the year, achieving our synergy target” · word for word
23 Feb 20268-K · 2.02, 8.01Revenue $8.91B (-3% y/y); Net Earnings (Loss) $1.24B (+10% y/y); Cash From (Used in) Operating Activities $3.65B (-2% y/y)earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $8.91B | -3% y/y |
| Net Earnings (Loss) · FY2025 | $1.24B | +10% y/y |
| Cash From (Used in) Operating Activities · FY2025 | $3.65B | -2% y/y |
| Capital expenditures · FY2025 | $2.15B | -7% y/y |
| Impairments · FY2025 | $920M | +104% y/y |
| Dividends on shares of common stock · FY2025 | $308M | -3% y/y |
Risks flagged
Impairment risk from oil and gas properties
“Impairments of $920M in 2025 vs $450M in 2024, indicating potential asset value decline.”
23 Feb 20268-K · 1.01Ovintiv USA Inc. and Ovintiv Royalty Holdings LLC entered into a Purchase and Sale Agreement with MidCon II BuyerCo, LLC, dated February 17, 2026. The agreement involves the sale of assets, but no financial terms are disclosed in the excerpbeing acquiredopen
Risks flagged
Execution risk on asset sale
“Agreement may have conditions; omitted schedules and exhibits.”
23 Feb 202610-KRisks named: Commodity Price Decline, Climate Transition Riskopen
Risks flagged
Commodity Price Decline
“A substantial or extended decline in oil, NGLs or natural gas prices, or a substantial increase in oil, NGLs and natural gas price differentials, could have a material adverse effect on our business, financial condition, results of operations, and the trading prices of our securities.” · word for word
Climate Transition Risk
“We are subject to risks and uncertainties arising from changing weather conditions as well as government, investor and consumer action in response to concerns over climate change and the transition to a lower-carbon economy that could reduce demand for the oil, NGLs and natural gas we produce; increase our operating costs; and limit the areas in which we may” · word for word
17 Feb 20268-K · 7.01Cash proceeds $3.00B; Net acres sold 360,000; Production (boe/d) 90,000open
Figures in the filing · each found in the filing text
| Cash proceeds | $3.00B | |
| Net acres sold | $360000.00 | |
| Production (boe/d) | $90000.00 |
3 Feb 20268-K · 2.01, 3.02, 7.01Transaction Value $2.70B; Cash Consideration 1,570,000,000; Shares Issued 30,076,903acquisitionopen
Figures in the filing · each found in the filing text
| Transaction Value | $2.70B | |
| Cash Consideration | $1.57B | |
| Shares Issued | 30,076,903 | |
| Expected Annual Cost Synergies | $100M | |
| Expected 2026 Production from Acquired Assets · FY2026 | $100000.00 |
Risks flagged
Integration risk and debt increase from acquisition financing.
“Cash consideration funded by borrowings; debt target to be met via divestiture of Anadarko assets.”
28 Jan 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Transaction still subject to customary closing conditions; any delay could impact expected close date.
“subject to the satisfaction or waiver of other customary closing conditions” · word for word
23 Jan 20268-K · 7.01Max aggregate Cash Consideration $1.57B; Max aggregate Share Consideration 30,100,000; Cash consideration per NuVista share $18.00open
Figures in the filing · each found in the filing text
| Max aggregate Cash Consideration · Q1-2026 | $1.57B | |
| Max aggregate Share Consideration · Q1-2026 | 30,100,000 | |
| Cash consideration per NuVista share · Q1-2026 | $18.00 | |
| Share consideration ratio · Q1-2026 | $0.34 |
Risks flagged
Regulatory approval risk from Investment Canada Act
“Transaction expected to close shortly after receipt of approval under the Investment Canada Act”
22 Dec 20258-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Integration risk and potential delays in closing.
“Transaction expected to close by end of Q1 2026, subject to conditions.”
16 Dec 20258-K · 7.01LNG capacity 500,000; Contract term 12open
Figures in the filing · each found in the filing text
| LNG capacity · Q4-2025 | $500000.00 | |
| Contract term · Q4-2025 | $12.00 |
Risks flagged
Execution risk: commercial operations at Cedar LNG anticipated in late 2028, subject to regulatory and construction timelines.
“Commencing with commercial operations at Cedar LNG, anticipated in late 2028.” · word for word
1 Dec 20258-K · 1.01, 2.03Term loan facility amount $1.20B; interest rate margin - base rate 100; interest rate margin - term SOFR 200open
Figures in the filing · each found in the filing text
| term loan facility amount · Q4-2025 | $1.20B | |
| interest rate margin - base rate · Q4-2025 | 100.0% | |
| interest rate margin - term SOFR · Q4-2025 | 200.0% | |
| debt to capitalization covenant · Q4-2025 | 60.0% |
Risks flagged
Increased leverage from acquisition financing may strain balance sheet if commodity prices decline.
“$1.2B term loan with 60% debt-to-capitalization covenant; acquisition integration risk.”
7 Nov 20258-K · 1.01, 3.02Entered a material definitive agreement (acquisition, partnership, or major contract); issued unregistered shares, diluting existing shareholdersopen
Risks flagged
Integration risk and potential regulatory hurdles.
“Acquisition of NuVista Energy Ltd. involves regulatory approvals.”
4 Nov 20258-K · 2.02, 8.01Total Revenues $2.07B (-11% y/y); Net Earnings (Loss) $148M (-71% y/y); Diluted Earnings Per Share $0.57 (-70% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q3-2025 | $2.07B | -11% y/y |
| Net Earnings (Loss) · Q3-2025 | $148M | -71% y/y |
| Diluted Earnings Per Share · Q3-2025 | $0.57 | -70% y/y |
| Operating Income (Loss) · Q3-2025 | $273M | -48% y/y |
| Impairments · Q3-2025 | $141M | |
| Capital Expenditures · Q3-2025 | $544M | +1% y/y |
| Cash From Operating Activities · Q3-2025 | $812M | -21% y/y |
Risks flagged
Significant impairments indicate potential overvaluation of assets.
“Impairments ... 871” · word for word
Declining revenue and earnings due to lower commodity prices and production.
“Net Earnings (Loss) ... $148 ... $507”
High debt levels with long-term debt of $4.4B.
“Long-Term Debt ... 4,393” · word for word
4 Nov 20258-K · 7.01Transaction Value 2,700,000,000; Acres Added 140,000; Expected Production 100,000open
Figures in the filing · each found in the filing text
| Transaction Value | $2.70B | |
| Acres Added | 140,000 | |
| Expected Production · FY2026 | $100000.00 | |
| Well Locations Added | 930 | |
| Annual Synergies | $100M |
Risks flagged
Integration risk: combining NuVista assets with existing operations.
“highly complementary to Ovintiv’s existing acreage” · word for word
Financing risk: debt increase to fund cash portion; buyback paused.
“temporarily paused its share buyback program for two quarters” · word for word
Divestiture execution risk for Anadarko assets.
“Divestiture process for Ovintiv’s Anadarko assets expected to commence in the first quarter of 2026” · word for word
4 Nov 202510-QOvintiv reported Q3 2025 earnings with net income of $148M, down 71% YoY, driven by lower commodity prices and a $141M impairment in Canadian operations.earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q3-2025 | $2.07B | -11% y/y |
| Net Earnings (Loss) · Q3-2025 | $148M | -71% y/y |
| Cash From (Used in) Operating Activities · Q3-2025 | $812M | -21% y/y |
| Capital expenditures · Q3-2025 | $544M | +1% y/y |
| Impairments · Canadian Operations · Q3-2025 | $141M | |
| Operating Income (Loss) · USA Operations · Q3-2025 | $398M | -21% y/y |
| Operating Income (Loss) · Canadian Operations · Q3-2025 | $-35M | |
| Product and service revenues · Q3-2025 | $1.73B | -3% y/y |
| Sales of purchased product · Q3-2025 | $289M | -28% y/y |
| Free Cash Flow · Q3-2025 | $268M | -45% y/y |
Risks flagged
Ceiling test impairment risk from low commodity prices
“For the three months ended September 30, 2025, the Company recognized a before-tax non-cash ceiling test impairment of $141 million (2024 - nil) in the Canadian Operations primarily resulting from the decline in the 12-month average trailing prices, which reduced proved reserves.” · word for word
Canadian Operations segment loss
“Operating Income (Loss) $ (35) $ 60”
Declining revenue and earnings
“Total Revenues 2,066 2,324; Net Earnings (Loss) $ 148 $ 507”
Ovintiv Inc. — questions
- What did Ovintiv Inc. file recently?
- 25 SEC filings in the last 12 months. Latest: 8-K on 2026-10-01 — Ovintiv renewed NCIB to buy back up to 26,973,037 shares (10% of float) over 12 months, consistent with 50-100% FCF return policy.
Every figure on this page comes from Ovintiv Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.